Key result
The exact dose of heparin needed during coronary interventions and the length of postprocedural heparin infusion remain unestablished.
Design
Editorial
Authors
Loading...
Discusses the historical context and ongoing uncertainty regarding the optimal dosing of heparin during percutaneous transluminal coronary angioplasty.
Discusses the historical context and ongoing uncertainty regarding the optimal dosing of heparin during percutaneous transluminal coronary angioplasty.
Garachemani et al. (1998) conducted an editorial in Percutaneous transluminal coronary angioplasty (PTCA). Heparin was evaluated. The exact dose of heparin needed during coronary interventions and the length of postprocedural heparin infusion remain unestablished.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: